SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "L773:1546 9530 OR L773:1546 9549 "

Search: L773:1546 9530 OR L773:1546 9549

  • Result 1-10 of 15
Sort/group result
   
EnumerationReferenceCoverFind
1.
  • Havmöller, R, et al. (author)
  • Atrial fibrillation in heart failure
  • 2012
  • In: Current heart failure reports. - : Springer Science and Business Media LLC. - 1546-9549 .- 1546-9530. ; 9:4, s. 309-18
  • Journal article (peer-reviewed)
  •  
2.
  •  
3.
  • Jaarsma, Tiny, et al. (author)
  • Sexual dysfunction in heart failure patients
  • 2014
  • In: Current Heart Failure Reports. - : Springer Science and Business Media LLC. - 1546-9530 .- 1546-9549. ; 11:3, s. 330-336
  • Journal article (peer-reviewed)abstract
    • Heart failure has a severe impact on different aspects of a patient’s life, including sexual function. Sexual problems are common in heart failure (HF) patients, both in men and women, and are not always adequately addressed and treated in the current health care system. Several factors have been described to be related to sexual problems, such as activity intolerance, psychological factors, physiological factors, cardiac medications, recreational habits and co-morbidity. The current review summarizes knowledge that can help clinicians treat sexual dysfunction in HF patients. After a good assessment, several steps are advised, including improving HF and co-morbid conditions, discussing psychosocial problems, worries and misunderstandings, managing risk factors and considering PDE-5 inhibitors or other libido enhancing agents.
  •  
4.
  • Kato, Naoko, et al. (author)
  • Learning self-care after left ventricular assist device implantation
  • 2014
  • In: Current Heart Failure Reports. - : Springer. - 1546-9530 .- 1546-9549. ; 11:3, s. 290-298
  • Journal article (peer-reviewed)abstract
    • The number of heart failure (HF) patients living with a left ventricular assist device (LVAD) as destination therapy is increasing. Successful long-term LVAD support includes a high degree of self-care by the patient and their caregiver, and also requires long-term support from a multidisciplinary team. All three components of self-care deserve special attention once an HF patient receives an LVAD, including activities regarding self-care maintenance (activities related both to the device and lifestyle), self-care monitoring (e.g., monitoring for complications or distress), and self-care management (e.g., handling alarms or coping with living with the device). For patients to perform optimal self-care once they are discharged, they need optimal education that focuses on knowledge and skills through a collaborative, adult learning approach.
  •  
5.
  • Kjellström, Barbro, et al. (author)
  • Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension : Ready for Clinical Practice and Guidelines?
  • 2020
  • In: Current Heart Failure Reports. - : Springer Nature. - 1546-9530 .- 1546-9549. ; 17:5, s. 181-191
  • Journal article (peer-reviewed)abstract
    • Purpose of Review Pulmonary arterial hypertension (PAH) is a progressive disease with high mortality. A greater understanding of the physiology and function of the cardiovascular system in PAH will help improve survival. This review covers the latest advances within cardiovascular magnetic resonance imaging (CMR) regarding diagnosis, evaluation of treatment, and prognostication of patients with PAH.Recent Findings New CMR measures that have been proven relevant in PAH include measures of ventricular and atrial volumes and function, tissue characterization, pulmonary artery velocities, and arterio-ventricular coupling.Summary CMR markers carry prognostic information relevant for clinical care such as treatment response and thereby can affect survival. Future research should investigate if CMR, as a non-invasive method, can improve existing measures or even provide new and better measures in the diagnosis, evaluation of treatment, and determination of prognosis of PAH.
  •  
6.
  •  
7.
  •  
8.
  •  
9.
  • Lund, Lars H, et al. (author)
  • Registry-Based Pragmatic Trials in Heart Failure : Current Experience and Future Directions
  • 2017
  • In: Current Heart Failure Reports. - : Springer Science and Business Media LLC. - 1546-9530 .- 1546-9549. ; 14:2, s. 59-70
  • Journal article (peer-reviewed)abstract
    • PURPOSE OF REVIEW: Randomized controlled trials (RCTs) in heart failure (HF) are becoming increasingly complex and expensive to conduct and if positive deliver expensive therapy tested only in selected populations.RECENT FINDINGS: Electronic health records and clinical cardiovascular quality registries are providing opportunities for pragmatic and registry-based prospective randomized clinical trials (RRCTs). Simplified regulatory, ethics, and consent procedures; recruitment integrated into real-world care; and simplified or automated baseline and outcome collection allow assessment of study power and feasibility, fast and efficient recruitment, delivery of generalizable findings at low cost, and potentially evidence-based and novel use of generic drugs with low costs to society. There have been no RRCTs in HF to date. Major challenges include generating funding, international collaboration, and the monitoring of safety and adherence for chronic HF treatments. Here, we use the Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF), to be conducted in the Swedish Heart Failure Registry, to exemplify the advantages and challenges of HF RRCTs.Summary: There have been no RRCTs in HF to date. Major challenges include generating funding, international collaboration, and the monitoring of safety and adherence for chronic HF treatments. Here, we use the Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF), to be conducted in the Swedish Heart Failure Registry, to exemplify the advantages and challenges of HF RRCTs.
  •  
10.
  • Lundgren, Johan, 1977-, et al. (author)
  • Can Cognitive Behaviour Therapy Be Beneficial for Heart Failure Patients?
  • 2015
  • In: Current Heart Failure Reports. - : Springer. - 1546-9530 .- 1546-9549. ; 12:2, s. 166-72
  • Research review (other academic/artistic)abstract
    • This review aims to summarize the theory of cognitive behavioural therapy (CBT) as well as the current evidence for whether CBT can be beneficial for patients with heart failure (HF). Depression and/or anxiety are common in HF patients. However, participation in disease management programmes does not seem to be beneficial for these problems. CBT, which focuses on the identification and changing of dysfunctional beliefs and thoughts and on behaviour therapy, is a possible treatment option. The number of CBT studies on HF is small and they are often not designed as randomized controlled trials. However, the studies on HF indicate that CBT can decrease depression as well as anxiety and suggest that relaxation exercises with elements of CBT may decrease symptom burden. Before implementation in clinical practice, more knowledge is needed about how CBT programmes should be designed, where CBT should be delivered and who should deliver CBT.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-10 of 15

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view